Abstract
2/2010
vol. 5
Review paper
Profits from biological treatment in inflammatory bowel disease patients
Przegląd Gastroenterologiczny 2010; 5 (2): 68–76
Online publish date: 2010/05/12
Colitis ulcerosa (CU) and Crohn disease (CD) belong to inflammatory bowel diseases (IBD). Characteristic for the disease are remissions and recurrences, when the pharmacological treatment is necessery. Unfortunatelly, although there are instructions and the aims of treatment are precised, optimal therapeutic procedures are not well defined. Conventional methods are not effective in the most serious cases. In this paper standard therapuetic procedures and newest trends in treatment of IBD are described.
Keywords
inflammatory bowel diseases, biological treatment, therapeutic procedures in inflammatory bowel diseases
Coverage in
Indexed in
Integrated with
